Kfir Oved, chairman, co-founder and CTO of MeMed Diagnostics, writes about the development of its new technology aiming to combat antibiotic misuse and antimicrobial resistance (AMR).
Read more here.
Kfir Oved, chairman, co-founder and CTO of MeMed Diagnostics, writes about the development of its new technology aiming to combat antibiotic misuse and antimicrobial resistance (AMR).
Read more here.
![[NeuReality in Forbes] IBM Research and NeuReality Announce Partnership For AI](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
